SAWAF AZIZ (SVP & CHIEF FINANCIAL OFFICER) received a stock award from THERAVANCE BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/4/2025ACC: 0001415889-25-006679
Officer· SVP & CHIEF FINANCIAL OFFICER
Since Feb 2026
+75K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
75K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+75K
Price / share
—
Trade value
—
% of position
25.1%
2/28/2025
299.14K→374.14K
Total
Net shares
+75K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 2/28/2025 | A · Award | +75K | — | — | 25.1% | 299.14K | 374.14K |
| Total | +75K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported